Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity.
By F. Magkos, G. Fraterrigo, Jun Yoshino, C. Luecking, Kyleigh Kirbach, Shannon C. Kelly, L. de las Fuentes, Songbing He, A. Okunade, B. Patterson and 1 more. Cell Metabolism, 2016
797 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Physiology
View Paper: https://www.semanticscholar.org/paper/0f2f36ca5ef330739f2bf66a0df31bbe31984733
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- A. Chait
- Laura J. den Hartigh
- Hannele Yki-Järvinen
- P. Scherer
- Amalia Gastaldelli
- Haiming Cao
- M. Blüher
In Epidemiology
- A. Chait
- Laura J. den Hartigh
- Hannele Yki-Järvinen
- A. Okunade
- B. Patterson
- Jamal Naderi
- M. Longo
- C. Miele
In Physiology
- A. Chait
- Laura J. den Hartigh
- Hannele Yki-Järvinen
- Jamal Naderi
- M. Longo
- C. Miele
- G. A. Raciti
- F. Beguinot
Citations in the corpus
- Once-Weekly Semaglutide in Adults with Overweight or Obesity. (2021, background): “, prediabetes, hypertension, and obstructive sleep apnea).(1,20,21,27) In the semaglutide group, approximately 70% of participants achieved a weight loss of at least 10%, and approximately 50% achieved a weight loss of at least 15%.”
- Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes (2020, background): “The improved glycemic control after weight loss is due, in part, to the dysregulated expression of genes involved in cholesterol flux, lipid synthesis, ECM remodeling, and oxidative stress (Magkos et al., 2016).”
- Why Does Obesity Cause Diabetes? (2022, background): “…plasma triglyceride and increased HDL-cholesterol concentrations, decreased fasting blood glucose and insulin concentrations, increased oral glucose tolerance and insulin sensitivity, and decreased risk of type 2 diabetes in people who are lean, overweight, or obese (Manolopoulos et al., 2010).”
- Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications (2019, background): “Nevertheless, these approaches are difficult to maintain in the long term [8].”
- Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease (2020, background): “It has been suggested that pronounced weight loss over time can lead to improvements in adipose tissue inflammation that were not observed in the same subjects following acute moderate weight loss (552).”
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. (2019, background): “Even 48 h of calorie restriction causes a marked decline in IHTG content (50), and at any given percent weight loss, the relative decrease in IHTG content is much greater than the relative decrease in whole-body or intra-abdominal adipose tissues (51).”